Cryofocus Medtech (Shanghai) Co (HKSE:06922) Liabilities-to-Assets : 0.14 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Cryofocus Medtech (Shanghai) Co's Total Liabilities for the quarter that ended in Jun. 2023 was HK$38.31 Mil. Cryofocus Medtech (Shanghai) Co's Total Assets for the quarter that ended in Jun. 2023 was HK$280.75 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2023 was 0.14.

Cryofocus Medtech (Shanghai) Co Liabilities-to-Assets Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Liabilities-to-Assets Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Liabilities-to-Assets

0.32

0.15

0.17

0.19

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Liabilities-to-Assets	Get a 7-Day Free Trial			0.15	-	0.17	0.14	0.19

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets falls into.

Cryofocus Medtech (Shanghai) Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Liabilities-to-Assets (A: Dec. 2022 )	=	Total Liabilities	/	Total Assets
	=	60.832	/	350.495
	=	0.17

Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2023 is calculated as

Liabilities-to-Assets (Q: Jun. 2023 )	=	Total Liabilities	/	Total Assets
	=	38.309	/	280.749
	=	0.14

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Cryofocus Medtech (Shanghai) Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Liabilities-to-Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines